(Q34104580)

31 July 2017

1 reference

title

Novel therapy in the treatment of scleroderma (English)

1 reference

31 July 2017

Wigley FM

1

1 reference

31 July 2017

Sule SD

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

31-48

1 reference

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Pathogenesis of scleroderma. Collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Recombinant interferon-gamma in the treatment of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Relaxin is a potent renal vasodilator in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Treatment of vasospastic disease with prostaglandin E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Oral Psoralen-UV-A for Systemic Scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

Angiotensin II Induces alpha3(IV) Collagen Expression in Cultured Murine Proximal Tubular Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.1.31

21 January 2018

Identifiers

DOI

10.1517/13543784.10.1.31

1 reference

31 July 2017

1 reference